Science

What becomes possible when antibodies do more.

Extending the reach of antibodies to new diseases.

95% of today's therapeutic antibodies work by blocking biology, leaving an enormous opportunity for biologics that can do more. By expanding the mechanisms antibodies can use, Metaphore broadens the scope of diseases antibody medicines can treat.

Many diseases require pathways to be activated. Others require signals to be tuned, multiple targets to be engaged, or several functions to work together in one simple medicine. These are therapeutic challenges that blocking alone cannot solve.

Metaphore's platform makes these antibody actions designable. This unlocks a wider therapeutic landscape, enabling new mechanisms, new targets, and new treatment possibilities for millions of patients.

What this enables.

To treat many diseases, you need medicines that do more than block biology.

Expanding what antibodies can do.

Many diseases rely more than blocking. Metaphore is designing antibodies with new therapeutic actions to address more complex biology.

  • Activate pathways

    Tune biology on to restore beneficial functions.

  • Bias signaling

    Precisely tune signaling for better outcomes.

  • Engage multiple targets

    Address complex biology through coordinated engagement.

  • Combine functions

    Unite activities in one molecule for greater therapeutic impact.

  • Selective antagonism

    Block the right spots while preserving what matters.

Our Platform

Where living biology directs antibody design.

Metaphore’s platform combines high throughput live-cell experimentation with machine learning to design antibodies that go beyond blocking.

Biology is constantly in motion. Proteins interact, change shape, and send complex signals that determine how cells behave. Yet traditional antibody discovery often begins with static structures or binding outside a protein’s natural environment—revealing where an antibody binds, but not always what it will do in a living system.

Instead of relying on static protein structures, Metaphore starts with functional data from living systems. Functional data describe what a molecule does beyond binding, including receptor activation, downstream signaling, and gene transcription. We measure biological activity in living cells  to understand what drives pathway activation, signaling bias, selectivity, multi-target engagement, and other complex therapeutic actions.

These data are interpreted by our AI/ML models that identify the features responsible for specific functional outcomes. Those insights become the foundation for designing antibody medicines with new capabilities.

With each design cycle, our platform learns from new functional data, improving its ability to design antibodies for specific therapeutic actions. This approach enables Metaphore to design molecules with precise therapeutic actions in weeks instead of years bringing our medicines to patients, faster.

01

Learn

Measure functional activity in living cells at scale to understand how proteins behave.

02

Design

Use functional data and machine learning to identify features that drive desired biological actions and design antibody candidates.

03

Build

Create antibody candidates designed for the intended therapeutic action.

04

Test

Refine and optimize properties through machine learning to test candidates in living systems and use the results to refine their function and medicine-like properties.

Applications

  • Unlock intractable targets

    Mechanism-informed functional data allows us to address high value targets that have been inaccessible to antibodies using traditional structure and binding-based methods.

  • Design for action

    We design antibodies to drive specific therapeutic actions, including agonism, signaling bias, and multi receptor activity from the outset.

  • Define specificity

    Functional mapping enables precise tuning to engage multiple targets of interest and to minimize off-target activation, all while driving the desired biological response.

  • Choose the ideal antibody-based modality

    Therapeutic actions can be designed across several antibody-based formats to match the needs of each disease.

Patient impact

New antibody actions. New possibilities for patients.

Metaphore is building this platform to create antibody medicines for diseases where blocking alone is not enough. By making new therapeutic actions designable, we aim to extend the reach of antibody medicine and create new treatment possibilities for patients.

Contact Metaphore
Patient smiling at her doctor